Search
Search Results
##search.searchResults.foundPlural##
-
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3421PDF: 2325HTML: 1406 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1831PDF: 817HTML: 1237 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1884PDF: 1333HTML: 245 -
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1499PDF: 849HTML: 964figures: 150table 1: 162table2: 159table3: 161 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7186PDF: 2346HTML: 1701Table 1.: 183Table 2.: 199Table 3.: 179Table 4.: 178 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2510PDF: 1567HTML: 2333Table1: 172 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1434PDF: 349HTML: 181 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1058PDF: 454HTML: 211 -
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1343PDF: 709HTML: 190 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1511PDF: 546HTML: 213 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1224PDF: 767HTML: 111 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2014PDF: 960HTML: 4046Cover Letter: 204Figure 1: 201Figure 2: 209Table 1: 186 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3980PDF: 1515HTML: 815 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1326PDF: 783HTML: 3100 -
Skin Involvement in Primary Systemic Amyloidosis
1529PDF: 859HTML: 4344Figure 1. Photographs showing (a) enlarged tongue with (b) teeth marks over the lateral margin and (c, d) multiple, papular lesions over lower chest wall: 158Figure 2. Microphotograph showing pink eosinophilic homogenous material in the dermis, H&E X 20: 114Figure 3. Pink eosinophilic material showing pale orange positivity with Congo red stain: 154 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1755PDF: 687HTML: 2082Untitled: 188Untitled: 137Untitled: 151Untitled: 138Untitled: 144Untitled: 160Untitled: 167 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3899PDF: 1262HTML: 2238 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1402PDF: 509HTML: 650 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1196PDF: 450HTML: 18539Figure 1: 151Figure 2: 136Figure 3: 152Figure 4: 185Figure 5: 155 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
776PDF: 772HTML: 95 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2050PDF: 1920HTML: 139 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1130PDF: 706HTML: 1327Figure 1: 153Figure 2: 150 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1098PDF: 453HTML: 193 -
-
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1685PDF: 848HTML: 357Fig1: 211Fig.2: 228Fig. 3: 159Fig. 5: 165Fig. 4: 196 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3242PDF: 688HTML: 697Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 163Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 158Table : Distribution of the sites of bleeding and their causes: 163







